1、2 0 2 3ESG ReportContentsA Note from Our Co-CEOsOur Approach to Environmental,Social and Governance(ESG)Transforming Cancer CareProduct Quality&SafetySupply Chain ManagementOur PeopleCorporate GovernanceEthics&ComplianceInformation SecurityEnvironmental Sustainability46816192234384247About This Repo
2、rtThis report includes disclosures that are informed by the Sustainability Accounting Standards Board(SASB)standards for the Biotechnology&Pharmaceuticals and Medical Equipment&Supplies industries.All financial information is reported in U.S.dollars,and unless otherwise stated,this report covers fis
3、cal years 2020,2021,and 2022,as well as some key activities that occurred through May 15,2023.2The information and opinions contained in this report are provided as of the date of this report and are subject to change without notice.Guardant Health does not undertake to update or revise any such sta
4、tements.This report represents current Guardant Health policy,practices and intent and is not intended to create legal rights or obligations.This report may contain or incorporate by reference public information not separately reviewed,approved,or endorsed by Guardant Health,and no representation,wa
5、rranty,or undertaking is made by Guardant Health as to the accuracy,reasonableness,or completeness of such information.Inclusion of information in this report is not an indication that the subject or information is material to Guardant Healths business or operating results.This report contains forwa
6、rd-looking statements within the meaning of federal securities laws,including statements regarding the potential utilities,values,benefits and advantages of Guardant Healths liquid biopsy tests or assays,which involve risks and uncertainties that could cause the actual results to differ materially f